Apocryphal FADS2 activity promotes fatty acid diversification in cancer-Reference-Cited by-同舟云学术

Apocryphal FADS2 activity promotes fatty acid diversification in cancer

Published:2021-02 Issue:6 Volume:34 Page:108738
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Young Reuben S.E.^ORCID,Bowman Andrew P.^ORCID,Williams Elizabeth D.^ORCID,Tousignant Kaylyn D.,Bidgood Charles L.^ORCID,Narreddula Venkateswara R.,Gupta Rajesh,Marshall David L.^ORCID,Poad Berwyck L.J.^ORCID,Nelson Colleen C.^ORCID,Ellis Shane R.,Heeren Ron M.A.,Sadowski Martin C.,Blanksby Stephen J.

Funder

Australian Research Council

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference56 articles.

1. X-ray structure of a mammalian stearoyl-CoA desaturase;Bai;Nature,2015

2. Faster raster matrix-assisted laser desorption/ionization mass spectrometry imaging of lipids at high lateral resolution;Barré;Int. J. Mass Spectrom.,2019

3. Lipid metabolic reprogramming in cancer cells;Beloribi-Djefaflia;Oncogenesis,2016

4. Non-glucose metabolism in cancer cells—is it all in the fat?;Biswas;Cancer Metastasis Rev.,2012

5. Improved sensitivity mass spectrometric detection of eicosanoids by charge reversal derivatization;Bollinger;Anal. Chem.,2010

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance;Pharmacological Research;2024-09

2. Unusual polyunsaturated fatty acids in edible marine worms identified by covalent adduct chemical ionization mass spectrometry;Food Chemistry;2024-09

3. Marching toward human lipidome project – Advancement of structural lipidomics;TrAC Trends in Analytical Chemistry;2024-08

4. Cross-Validation of Lipid Structure Assignment Using Orthogonal Ion Activation Modalities on the Same Mass Spectrometer;Journal of the American Society for Mass Spectrometry;2024-07-22

5. Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer;Cell Death & Disease;2024-07-18